As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced #clinical trials Lilach Baumer17:4228.03.18 Pharmaceutical company InSight Biopharmaceuticals Ltd. has signed a…

MIXiii-BIOMED 2018 - CALL FOR COMPANY PRESENTATIONS MIXiii-Biomed 2018 Preliminary Conference Program is online. As the leading event of Israel’s life sciences industry, MIXiii-BIOMED is once again providing a unique program,…